These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31555517)

  • 21. Elevated PD-L1 expression predicts poor survival outcomes in patients with cervical cancer.
    Gu X; Dong M; Liu Z; Mi Y; Yang J; Zhang Z; Liu K; Jiang L; Zhang Y; Dong S; Shi Y
    Cancer Cell Int; 2019; 19():146. PubMed ID: 31143091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of PD-L1 expression and NLR as prognostic marker in patients with surgically resected non-small cell lung cancer.
    Wang X; Cao L; Li S; Wang F; Huang D; Jiang R
    J Cancer; 2019; 10(26):6703-6710. PubMed ID: 31777599
    [No Abstract]   [Full Text] [Related]  

  • 23. Prognostic role of programmed death-ligand 1 expression in patients with biliary tract cancer: a meta-analysis.
    Lei C; Peng X; Gong X; Fan Y; Wu S; Liu N; Li L; Huang J; Zheng G; Long Z
    Aging (Albany NY); 2019 Dec; 11(24):12568-12580. PubMed ID: 31881008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic and clinicopathological value of PD-L1 in colorectal cancer: a systematic review and meta-analysis.
    Yang L; Xue R; Pan C
    Onco Targets Ther; 2019; 12():3671-3682. PubMed ID: 31190869
    [No Abstract]   [Full Text] [Related]  

  • 25. Prognostic and Clinicopathological Value of PD-L1 in Melanoma: A Meta-Analysis.
    Xu J; Wang F; Yan Y; Zhang Y; Du Y; Sun G
    Am J Med Sci; 2020 Jun; 359(6):339-346. PubMed ID: 32498941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of programmed cell death ligand-1 expression in ovarian cancer: an updated meta-analysis.
    Piao J; Lim HJ; Lee M
    Obstet Gynecol Sci; 2020 May; 63(3):346-356. PubMed ID: 32489980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
    Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Value of Programmed Cell Death 1 Ligand-1 in Patients With Bone and Soft Tissue Sarcomas: A Systemic and Comprehensive Meta-Analysis Based on 3,680 Patients.
    Wang F; Yu T; Ma C; Yuan H; Zhang H; Zhang Z
    Front Oncol; 2020; 10():749. PubMed ID: 32582532
    [No Abstract]   [Full Text] [Related]  

  • 29. The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patients.
    Zhang M; Dong Y; Liu H; Wang Y; Zhao S; Xuan Q; Wang Y; Zhang Q
    Sci Rep; 2016 Nov; 6():37933. PubMed ID: 27892511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic and clinicopathological utility of programmed death-ligand 1 in malignant pleural mesothelioma: A meta-analysis.
    Zhang F; Gong W
    Int Immunopharmacol; 2020 Jun; 83():106481. PubMed ID: 32339986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression status and prognostic significance of programmed cell death 1 ligand 1 in gastrointestinal tract cancer: a systematic review and meta-analysis.
    Huang B; Chen L; Bao C; Sun C; Li J; Wang L; Zhang X
    Onco Targets Ther; 2015; 8():2617-25. PubMed ID: 26451118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between blood-based tumor mutation burden level and efficacy of PD-1/PD-L1 inhibitors in advanced non-small cell lung cancer: a systematic review and meta-analysis.
    Ba H; Liu L; Peng Q; Chen J; Zhu YD
    BMC Cancer; 2021 Nov; 21(1):1220. PubMed ID: 34774004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of PD-L1 expression in resected lung adenocarcinoma and potential molecular mechanisms.
    Ma J; Chi D; Wang Y; Yan Y; Zhao S; Liu H; Jing J; Pu H; Zhang M
    J Cancer; 2018; 9(19):3489-3499. PubMed ID: 30310505
    [No Abstract]   [Full Text] [Related]  

  • 34. The predictive implication of programmed cell death ligand 1 expression in extranodal natural killer/T-Cell lymphoma and its correlation with clinicopathological features: a systematic review and meta-analysis.
    Li W; Zheng Q; Luo X; Zhang X; Zheng X; Yang Y
    Transl Cancer Res; 2023 Aug; 12(8):2115-2127. PubMed ID: 37701117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of programmed cell death-ligand 1 expression in patients with non-small-cell lung cancer: evidence from an updated meta-analysis.
    Zhong A; Xing Y; Pan X; Shi M; Xu H
    Onco Targets Ther; 2015; 8():3595-601. PubMed ID: 26664143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Value of Programmed Cell Death 1 Ligand-1 (PD-L1) or PD-1 Expression in Patients with Osteosarcoma: A Meta-Analysis.
    Huang X; Zhang W; Zhang Z; Shi D; Wu F; Zhong B; Shao Z
    J Cancer; 2018; 9(14):2525-2531. PubMed ID: 30026851
    [No Abstract]   [Full Text] [Related]  

  • 37. The prognostic role of PD-1, PD-L1, ALK, and ROS1 proteins expression in non-small cell lung carcinoma patients from Egypt.
    Bahnassy AA; Ismail H; Mohanad M; El-Bastawisy A; Yousef HF
    J Egypt Natl Canc Inst; 2022 May; 34(1):23. PubMed ID: 35644823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Positive PD-L1 expression is predictive for patients with advanced EGFR wild-type non-small cell lung cancer treated with gemcitabine and cisplatin.
    Qiu Y; Jiang J; Zhang M; Qin Y
    Oncol Lett; 2019 Jul; 18(1):161-168. PubMed ID: 31289485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PD-L1 and prognosis in patients with malignant pleural mesothelioma: a meta-analysis and bioinformatics study.
    Jin L; Gu W; Li X; Xie L; Wang L; Chen Z
    Ther Adv Med Oncol; 2020; 12():1758835920962362. PubMed ID: 33062064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The detection value of PD-L1 expression in biopsy specimens and surgical resection specimens in non-small cell lung cancer: a meta-analysis.
    Wang Y; Wu J; Deng J; She Y; Chen C
    J Thorac Dis; 2021 Jul; 13(7):4301-4310. PubMed ID: 34422357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.